Crossmark

CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model

Published Online: 2021-09-01

Published Print: 2022-05

Authors

Ng, Yu Yang

Du, Zhicheng

Zhang, Xi

Chng, Wee Joo

Wang, Shu http://orcid.org/0000-0003-4107-2812
License Information

Text and Data Mining valid from 2021-09-01

Version of Record valid from 2021-09-01
More Information

Article History

Received: 27 November 2020

Revised: 27 May 2021

Accepted: 22 June 2021

First Online: 1 September 2021

Competing interests

: SW and YYN have filed patent applications related to CAR technologies and could potentially receive licensing royalties in future.

Document is current